Home › Funds › Strid Group, LLC › MDGL
Strid Group, LLC position in MDGL
MADRIGAL PHARMACEUTICALS INC · Health Care
Strid Group, LLC reported holding 2,500 shares of MDGL (MADRIGAL PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$1.3M, representing 0.14% of its reported portfolio and ranking #35 among its reported holdings. Strid Group, LLC has disclosed MDGL holdings in 6 of the last 6 reported quarters, going back to Q2 2025.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Strid Group, LLC's MDGL position evolved
Strid Group, LLC first disclosed a stake in MDGL in Q2 2025 at 2,500 shares (US$757K). The position peaked in Q4 2025 at 2,500 shares, worth US$1.5M. Across 6 filings, Strid Group, LLC held the position steady without any share-count change. The most recent filing (Q3 2026) shows 2,500 shares valued at US$1.3M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2025 | 2.50K | $756.60K | New |
| Q3 2025 | 2.50K | $1.15M | Hold |
| Q4 2025 | 2.50K | $1.46M | Hold |
| Q1 2026 | 2.50K | $1.31M | Hold |
| Q2 2026 | 2.50K | $1.34M | Hold |
| Q3 2026 | 2.50K | $1.26M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About MDGL and 13F data
MDGL (MADRIGAL PHARMACEUTICALS INC) is a Health Care company. 45 other funds we track also report a position in MDGL — the largest reported positions include BAKER BROS. ADVISORS LP (US$1.15B), RTW INVESTMENTS, LP (US$1.07B), Janus Henderson Group (US$1.05B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding MDGL
- BAKER BROS. ADVISORS LP 2.14M sh · $1.15B · Q2 2026
- RTW INVESTMENTS, LP 1.99M sh · $1.07B · Q2 2026
- Janus Henderson Group 2.02M sh · $1.05B · Q1 2026
- Jupiter Topco LLC 1.94M sh · $1.04B · Q2 2026
- Avoro Capital Advisors LLC 1.83M sh · $984.41M · Q2 2026
- Paulson & Co 1.34M sh · $719.52M · Q2 2026
- PAULSON & CO. INC. 1.34M sh · $719.52M · Q2 2026
- WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC 337.04K sh · $169.85M · Q3 2026
- ARMISTICE CAPITAL, LLC 288.00K sh · $154.64M · Q2 2026
- Rock Springs Capital Management LP 175.00K sh · $93.97M · Q2 2026
More on Strid Group, LLC
FAQ
How long has Strid Group, LLC held MDGL?
Strid Group, LLC has disclosed MDGL holdings in 6 of the last 6 reported quarters, going back to Q2 2025.
What is Strid Group, LLC's current position in MDGL?
As of Q3 2026, Strid Group, LLC holds 2.50K shares of MDGL (MADRIGAL PHARMACEUTICALS INC), valued at $1.26M, representing 0.14% of its reported portfolio and ranking #35.
Has Strid Group, LLC been buying or selling MDGL?
In the latest 13F filing (Q3 2026), Strid Group, LLC held unchanged its position in MDGL. The position peaked in Q4 2025 at 2.50K shares.
Which other funds hold MDGL?
Other major institutional holders of MDGL include BAKER BROS. ADVISORS LP, RTW INVESTMENTS, LP, Janus Henderson Group, among 45 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.